Literature DB >> 7497775

Acute epiglottitis. An 18-year experience in Rhode Island.

M F Mayo-Smith1, J W Spinale, C J Donskey, M Yukawa, R H Li, F J Schiffman.   

Abstract

OBJECTIVE: To assess the incidence, clinical characteristics, management, and outcome of epiglottitis in a defined population over an 18-year period.
DESIGN: Case series.
SETTING: The state of Rhode Island, 1975 through 1992. PATIENTS OR OTHER PARTICIPANTS: Cases who met predetermined criteria for acute epiglottitis identified from hospital discharges and the State Medical Examiner's log of prehospitalization deaths. MAIN OUTCOME MEASURES: Incidence by year and age, clinical presentation, results of diagnostic evaluations, management, and outcome.
RESULTS: Four hundred seven cases were identified, 134 in children and 273 in adults. Incidence in children dropped from 38 cases in the first 3 years of the study to 1 case in the last 3 years (p < 0.001). Adult cases increased from 17 in the first 3 years to 69 in the last 3 years (p < 0.001). Seventy-nine percent of adults and 32% of children were treated without an artificial airway. Factors associated with airway obstruction included symptomatic respiratory difficulty, stridor, drooling, shorter duration of symptoms, enlarged epiglottis on radiograph, and Haemophilus influenzae bacteremia (p < 0.001 for each). Twelve patients died (3 children and 9 adults), with all cases of fatal respiratory obstruction occurring within 12 h of presentation.
CONCLUSIONS: There have been significant changes in the clinical epidemiology of epiglottitis, which now occurs almost exclusively in adults, often with less severe symptoms and a lower incidence of H influenzae infection. While careful observation is indicated for all patients, the data suggest that those with certain clinical characteristics can be treated safely without an immediate artificial airway.

Entities:  

Mesh:

Year:  1995        PMID: 7497775     DOI: 10.1378/chest.108.6.1640

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Adult epiglottitis.

Authors:  Che-Kim Tan; Khee-Siang Chan; Kuo-Chen Cheng
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

2.  Thumb sign: acute epiglottitis.

Authors:  Mina Takata; Tatsuya Fujikawa; Rieko Goto
Journal:  BMJ Case Rep       Date:  2016-05-31

3.  Acute epiglottitis: a retrospective review of 47 patients in Kuwait.

Authors:  Imtiaz Majid Qazi; Abdul Mohsin Jafar; Khalid Al Abdul Hadi; Zakir Hussain
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-01-09

4.  Acute epiglottitis in adults - a recent review in an Indian hospital.

Authors:  Saurav Sarkar; A Roychoudhury; B K Roychaudhuri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-09-27

5.  Diagnosis and management of supraglottitis (epiglottitis).

Authors:  Fergal Glynn; John E Fenton
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

6.  Disseminated Herpes Simplex Infection Presenting as Acute Supraglottitis in an Adult.

Authors:  Eve M R Bowers; Brandon I Esianor; Kyle Kimura; James S Lewis; Michael C Topf
Journal:  Head Neck Pathol       Date:  2020-12-28

Review 7.  Upper Airway Obstruction in Children.

Authors:  Anirban Mandal; Sushil K Kabra; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2015-06-25       Impact factor: 5.319

8.  Invasive Haemophilus influenzae type b disease in elderly nursing home residents: two related cases.

Authors:  T C Heath; M C Hewitt; B Jalaludin; C Roberts; A G Capon; P Jelfs; G L Gilbert
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

9.  Fulminant meningococcal supraglottitis: An emerging infectious syndrome?

Authors:  E Schwam; J Cox
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  A rare case of acute epiglottitis due to Staphylococcus aureus in an adult.

Authors:  Clare Harris; Lisa Sharkey; George Koshy; Nicola Simler; Johannis Andreas Karas
Journal:  Infect Dis Rep       Date:  2012-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.